
Enzalutamide 40 mg (Obnyx) is an anti-androgen medicine used to treat certain types of prostate cancer, including advanced and metastatic disease. It works by blocking the effects of male hormones called androgens, such as testosterone, which can promote the growth of prostate cancer cells. This helps slow disease progression and supports long-term cancer management under the supervision of an oncologist.
| Generic name | Enzalutamide |
| Strength | 40 mg |
| Manufacturer | Zydus |
| Package size | 28 Capsules |
| Used for | Various types of prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Enzalutamide is an androgen receptor inhibitor that blocks the action of testosterone and other male hormones on prostate cancer cells. By preventing these hormones from activating androgen receptors and stimulating cancer-cell growth, it helps slow the spread and progression of prostate cancer.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.